心脏移植受者长期(>10年)心血管结局预测:负荷锝-99m替曲膦心肌灌注显像的价值
本研究纳入166例心脏移植受者,评估负荷99mTc-替曲膦SPECT心肌灌注显像对全因死亡和心脏事件的长期预后价值。中位随访12.8年期间,109例(66%)死亡,其中67例(40%)为心源性死亡,5例(3%)发生非致死性心肌梗死。负荷SPECT正常的受者预后显著优于异常者,可逆性灌注缺损是全因死亡、心源性死亡和主要心脏事件的显著预测因子。
要点
- 负荷99mTc-替曲膦SPECT心肌灌注显像可为心脏移植受者提供有价值的长期预后信息。
- 负荷SPECT正常的受者预后显著优于异常者,差异持续至初始检查后5年。
- 可逆性灌注缺损是整个随访期间全因死亡、心源性死亡和主要心脏事件的显著预测因子。
核心结论
- 负荷99mTc-替曲膦SPECT心肌灌注显像可为心脏移植受者长期结局预测提供有价值的预后信息。
- 负荷SPECT正常的心脏移植受者预后显著优于异常者,差异持续至初始检查后5年。
- 可逆性灌注缺损是整个随访期间全因死亡、心源性死亡和主要心脏事件的显著预测因子。
研究设计与样本
- 研究纳入166例心脏移植受者(平均年龄54±10岁,84%为男性),因评估心脏移植物血管病而接受运动或多巴酚丁胺负荷99mTc-替曲膦SPECT心肌灌注显像。
- SPECT异常定义为存在固定或可逆性灌注缺损。
- 终点为全因死亡、心源性死亡和非致死性心肌梗死。
主要发现
- 55例(33%)患者检出心肌灌注显像异常,其中固定缺损28例(17%)、部分可逆缺损17例(10%)、完全可逆缺损10例(6%)。
- 中位随访12.8年(范围0-15年,平均随访9.5年)期间,109例(66%)死亡(全因死亡),其中67例(40%)为心源性死亡,5例(3%)发生非致死性心肌梗死。
- 负荷99mTc-替曲膦SPECT正常的心脏移植受者预后显著优于异常者,差异持续至初始检查后5年。
- 可逆性灌注缺损是整个随访期间全因死亡、心源性死亡和主要心脏事件的显著预测因子。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Myocardial perfusion imaging (MPI) using single-photon emission computed tomography (SPECT) is useful in the evaluation of cardiac allograft vasculopathy (CAV) in heart transplant (HTx) recipients. The current study evaluated the long-term prognostic value of stress SPECT MPI for predicting all-cause mortality and cardiac events in HTx recipients. METHODS: The study population consisted of 166 HTx recipients (mean age 54 ± 10 years, 84% male) who underwent exercise or dobutamine stress 99mTc-tetrofosmin SPECT MPI for the assessment of CAV. An abnormal SPECT MPI was defined as the presence of a fixed or a reversible perfusion defect. Endpoints were all-cause mortality, cardiac mortality, and non-fatal myocardial infarction (MI). RESULTS: MPI abnormalities were detected in 55 patients (33%), including fixed defects in 28 patients (17%), partially reversible in 17 patients (10%), and completely reversible defects in 10 patients (6%). During a median follow-up of 12.8 years (range 0-15, mean follow-up 9.5 years), 109 (66%) patients died (all-cause mortality), of which 67 (40%) were due to cardiac causes. A total of 5 (3%) patients experienced a non-fatal MI. HTx recipients with a normal stress 99mTc-tetrofosmin SPECT MPI had a significantly better prognosis as compared with those with an abnormal study, up to 5 years after the initial test. The presence of a reversible perfusion defect was a significant predictor of all-cause mortality, cardiac mortality, and major cardiac events, during the entire follow-up period. CONCLUSIONS: Stress 99mTc-tetrofosmin SPECT MPI provides valuable prognostic information for the prediction of long-term outcome in HTx recipients. Patients with a normal stress 99mTc-tetrofosmin SPECT MPI have a significantly better prognosis as compared with those with an abnormal study, up to 5 years after initial testing.
引用
- Veenis JF, Boiten HJ, van den Berge JC, et al. Prediction of long-term (> 10 year) cardiovascular outcomes in heart transplant recipients: Value of stress technetium-99m tetrofosmin myocardial perfusion imaging. J Nucl Cardiol. 2017. PMID: 29116562. doi:10.1007/s12350-017-1089-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。